260 related articles for article (PubMed ID: 10815831)
1. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model.
Sciadini MF; Johnson KD
J Orthop Res; 2000 Mar; 18(2):289-302. PubMed ID: 10815831
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bovine-derived bone protein with a natural coral carrier as a bone-graft substitute in a canine segmental defect model.
Sciadini MF; Dawson JM; Johnson KD
J Orthop Res; 1997 Nov; 15(6):844-57. PubMed ID: 9497809
[TBL] [Abstract][Full Text] [Related]
3. Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model.
Sciadini MF; Dawson JM; Johnson KD
J Orthop Trauma; 1997 Oct; 11(7):496-508. PubMed ID: 9334951
[TBL] [Abstract][Full Text] [Related]
4. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
5. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge.
Zabka AG; Pluhar GE; Edwards RB; Manley PA; Hayashi K; Heiner JP; Kalscheur VL; Seeherman HJ; Markel
J Orthop Res; 2001 Mar; 19(2):318-27. PubMed ID: 11347707
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates.
Cook SD; Wolfe MW; Salkeld SL; Rueger DC
J Bone Joint Surg Am; 1995 May; 77(5):734-50. PubMed ID: 7744899
[TBL] [Abstract][Full Text] [Related]
7. Improved healing efficacy in canine ulnar segmental defects with increasing recombinant human bone morphogenetic protein-2/allograft ratios.
Jones CB; Sabatino CT; Badura JM; Sietsema DL; Marotta JS
J Orthop Trauma; 2008 Sep; 22(8):550-9. PubMed ID: 18758287
[TBL] [Abstract][Full Text] [Related]
8. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone.
Salkeld SL; Patron LP; Barrack RL; Cook SD
J Bone Joint Surg Am; 2001 Jun; 83(6):803-16. PubMed ID: 11407788
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
10. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model.
Pluhar GE; Manley PA; Heiner JP; Vanderby R; Seeherman HJ; Markel MD
J Orthop Res; 2001 Mar; 19(2):308-17. PubMed ID: 11347706
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ground cortical autograft as a bone graft material in a new canine bilateral segmental long bone defect model.
Johnson KD; August A; Sciadini MF; Smith C
J Orthop Trauma; 1996; 10(1):28-36. PubMed ID: 8926552
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur.
Chen X; Schmidt AH; Tsukayama DT; Bourgeault CA; Lew WD
J Bone Joint Surg Am; 2006 Jul; 88(7):1510-23. PubMed ID: 16818977
[TBL] [Abstract][Full Text] [Related]
14. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model.
Wheeler DL; Chamberland DL; Schmitt JM; Buck DC; Brekke JH; Hollinger JO; Joh SP; Suh KW
J Biomed Mater Res; 1998; 43(4):365-73. PubMed ID: 9855195
[TBL] [Abstract][Full Text] [Related]
15. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.
Sumner DR; Turner TM; Urban RM; Virdi AS; Inoue N
J Bone Joint Surg Am; 2006 Apr; 88(4):806-17. PubMed ID: 16595471
[TBL] [Abstract][Full Text] [Related]
16. Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1.
Fukuroku J; Inoue N; Rafiee B; Sim FH; Frassica FJ; Chao EY
J Bone Joint Surg Am; 2007 Jul; 89(7):1486-96. PubMed ID: 17606787
[TBL] [Abstract][Full Text] [Related]
17. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
[TBL] [Abstract][Full Text] [Related]
19. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs.
Itoh T; Mochizuki M; Nishimura R; Matsunaga S; Kadosawa T; Kokubo S; Yokota S; Sasaki N
J Vet Med Sci; 1998 Apr; 60(4):451-8. PubMed ID: 9592717
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model.
Bouxsein ML; Turek TJ; Blake CA; D'Augusta D; Li X; Stevens M; Seeherman HJ; Wozney JM
J Bone Joint Surg Am; 2001 Aug; 83(8):1219-30. PubMed ID: 11507131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
